Narcolepsy Market to 2027- Global Analysis and Forecasts by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography
- THE3206959
- 156 Pages
- February 2019
- Diagnostic and Biotech
The growth of the narcolepsy market is primarily attributed to the rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, side effects and risks associated with the narcolepsy medications and delayed diagnosis and misdiagnosis of the disease are likely to pose a negative impact on the market growth. On the other hand, robust pipeline of drugs intended for the treatment of narcolepsy is likely to have a positive impact on the growth of the global narcolepsy market in the coming years. The range of sleep disorders that are treated by neurologists is wide and includes conditions such as insomnia, sleep apnea, restless legs syndrome, and narcolepsy. These disorders cause disruptions in the normal sleep-wake mechanisms causing endogenous abnormalities. Neurological sleep related disorders is an emerging problem as the population is ageing at a rapid rate. According to the National Institute of Health (NIH), approximately 40 million Americans suffer from neurological diseases in the US, whereas additional 20 million people experience occasional sleeping problems. Sleep attacks are not limited to periods of dull or low engagement activities, but can happen during school or work hours, in the middle of a conversation, while eating, while exercising or playing sports, or even while driving. The increasing prevalence of neurological sleep disorders and narcolepsy is likely to foster the growth of market in the coming years.
In 2018, the narcolepsy with cataplexy segment held a largest market share of 65.1% of the narcolepsy market, by type. This segment is also expected to dominate the market in 2027 owing to its significant prevalence among patients suffering with narcolepsy. Episodes of cataplexy are reported to be encountered among 55-60% of patients suffering with narcolepsy. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 9.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.
Global narcolepsy market, based on product was segmented into sodium oxybate, CNS stimulants and antidepressants. Sodium oxybate segment is anticipated to grow at a CAGR of 9.8% during the forecast period. Sodium oxybate is the one of the primary medication recommended by specialists to patients suffering with narcolepsy. The high cost of the branded counterparts, availability of reimbursement with certain regions as well as approval of the drug in majority of the top markets is likely to contribute to the growth and dominance of the segment. Sodium is oxybate is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.
Some of the major primary and secondary sources for narcolepsy included in the report are World Health Organization (WHO), European Medical Agency (EMA), National Health Commission (NHC), China National Drug Administration (CNDA), Food & Drug Administration (FDA), National Institute of Neurological Disorders and Strokes, International Federation of Pharmaceutical Manufacturers & Associations and others.
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Global Narcolepsy Market - By Type
1.3.2 Global Narcolepsy Market - By Product
1.3.3 Global Narcolepsy Market - By Distribution Channel
1.3.4 Global Narcolepsy Market - By Geography
2. GLOBAL NARCOLEPSY MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. GLOBAL NARCOLEPSY MARKET - MARKET LANDSCAPE
4.1 OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis
5. GLOBAL NARCOLEPSY MARKET - KEY MARKET DYNAMICS
5.1 KEY MARKET DRIVERS
5.1.1 Rising Prevalence of Sleep Related Neurological Disorders
5.1.2 Emerging Local Pharmaceutical and Biopharmaceutical Companies
5.1.3 Increasing Awareness Regarding Neurological Disorders
5.2 KEY MARKET RESTRAINTS
5.2.1 Side Effects and Risks Associated with Narcolepsy Medications
5.2.2 Delayed Diagnosis or Misdiagnosis of Narcolepsy
5.3 KEY MARKET OPPORTUNITIES
5.3.1 Robust Pipeline Drugs for Narcolepsy
5.4 FUTURE TRENDS
5.4.1 New Treatments for Narcolepsy
5.5 IMPACT ANALYSIS
6. NARCOLEPSY MARKET - GLOBAL ANALYSIS
6.1 GLOBAL NARCOLEPSY MARKET REVENUE FORECASTS AND ANALYSIS
6.2 GLOBAL NARCOLEPSY MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Jazz Pharmaceuticals plc
6.3.2 Teva Pharmaceutical Industries Ltd.
6.4 BRAND ANALAYSIS
6.4.1 Marketed Drugs:
6.4.2 Provigil
6.4.2.1 Overview:
6.4.2.2 Drug Description:
6.4.2.3 Advantages & Disadvantages:
6.4.3 Xyrem
6.4.3.1 Overview:
6.4.3.2 Drug Description:
6.4.3.3 Advantages & Disadvantages:
6.4.4 Nuvigil
6.4.4.1 Overview:
6.4.4.2 Drug Description:
6.4.4.3 Advantages & Disadvantages:
6.5 PIPELINE ANALYSIS
7. NARCOLEPSY MARKET ANALYSIS AND FORECASTS TO 2027 - TYPE
7.1 OVERVIEW
7.2 TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3 NARCOLEPSY WITH CATAPLEXY MARKET
7.3.1 Overview
7.3.2 Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
7.4 NARCOLEPSY WITHOUT CATAPLEXY MARKET
7.4.1 Overview
7.4.2 Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
7.5 SECONDARY NARCOLEPSY MARKET
7.5.1 Overview
7.5.2 Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)
8. NARCOLEPSY MARKET ANALYSIS AND FORECASTS TO 2027 - PRODUCT
8.1 OVERVIEW
8.2 PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3 CENTRAL NERVOUS SYSTEM STIMULANTS MARKET
8.3.1 Overview
8.3.2 Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)
8.4 SODIUM OXYBATE MARKET
8.4.1 Overview
8.4.2 Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)
8.5 ANTIDEPRESSANTS MARKET
8.5.1 Overview
8.5.2 Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)
9. NARCOLEPSY MARKET ANALYSIS AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DISTRIBUTION CHANNEL MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3 HOSPITAL PHARMACIES MARKET
9.3.1 Overview
9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.4 RETAIL PHARMACIES MARKET
9.4.1 Overview
9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
10. NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1 NORTH AMERICA NARCOLEPSY MARKET
10.1.1 Overview
10.1.2 North America Narcolepsy Market Revenue And Forecasts to 2027 (US$ Mn)
10.1.3 North America Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.5 North America Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.6 North America Narcolepsy Market Revenue And Forecasts to 2027, By Country (%)
10.1.7 US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 US Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.2 US Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3 US Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.9 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Canada Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.2 Canada Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.10.3 Canada Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.11 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12.1 Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.2 Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.12.3 Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2 EUROPE NARCOLEPSY MARKET
10.2.1 Overview
10.2.2 Europe Narcolepsy market revenue Overview, by Country (2017) (us$ mn)
10.2.3 Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.4 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.5 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.6 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.7 Europe Narcolepsy market Revenue and Forecasts to 2027, By Country (%)
10.2.8 Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9 Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.9.2 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.9.3 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.10 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.11.2 UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.11.3 UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.12 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.13 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.13.1 France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.13.2 France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.13.3 France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.14 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15.1 Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.15.2 Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.15.3 Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.16 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17.1 Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.17.2 Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.17.3 Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3 ASIA PACIFIC NARCOLEPSY MARKET
10.3.1 Overview
10.3.2 Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.4 Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.5 Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.6 Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8 China Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.1 China Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.8.2 China Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.8.3 China Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.9 Japan Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10 Japan Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.1 Japan Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.10.2 Japan Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.10.3 Japan Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.11 India Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.12 India Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.12.1 India Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.12.2 India Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.12.3 India Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.13 Australia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14 Australia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14.1 Australia Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.14.2 Australia Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.14.3 Australia Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.15 South Korea Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16 South Korea Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16.1 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.16.2 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.16.3 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4 MIDDLE EAST & AFRICA NARCOLEPSY MARKET
10.4.1 Middle East & Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2 Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.3 Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.4 Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.5 Middle East & Africa Narcolepsy market Revenue and Forecasts to 2027, By Country (%)
10.4.6 UAE Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7 UAE Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.7.2 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.7.3 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.8 Saudi Arabia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9 Saudi Arabia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.1 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.9.2 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.9.3 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.10 South Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11 South Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11.1 South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.11.2 South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.11.3 South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5 SOUTH AND CENTRAL AMERICA NARCOLEPSY MARKET
10.5.1 Overview
10.5.2 South and Central America Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.4 South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.5 South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5.6 South and Central America Narcolepsy Market Share by Country, 2017 and 2027 (%)
10.5.7 Brazil Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8 Brazil Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.1 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.8.2 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.8.3 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5.9 Argentina Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.10 Argentina Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
10.5.10.1 Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.10.2 Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.10.3 Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11. NARCOLEPSY MARKET - INDUSTRY LANDSCAPE
11.1 OVERVIEW
11.2 COMPARATIVE COMPANY ANALYSIS
11.3 GROWTH STRATEGIES IN THE NARCOLEPSY MARKET, 2015-2018
11.4 ORGANIC GROWTH STRATEGIES
11.4.1 Overview
11.4.2 Expansions
11.4.3 Product Launches
11.4.4 Other Organic Growth Strategies
11.5 INORGANIC GROWTH STRATEGIES
11.5.1 Overview
11.5.2 Agreements
11.5.3 Acquisitions
11.5.4 Other Inorganic Growth Strategies
12. NARCOLEPSY MARKET -KEY COMPANY PROFILES
12.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 Swot Analysis
12.1.6 Key Developments
12.2 JAZZ PHARMACEUTICALS PLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ARENA PHARMACEUTICALS, INC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GRAYMARK HEALTHCARE, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 NOVARTIS AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Information
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Pipeline
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 MYLAN N.V.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 BIOPROJET
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SHIONOGI & CO., LTD.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 Product Pipeline
12.9.6 SWOT Analysis
12.9.7 Key Developments
12.10 LIGAND PHARMACEUTICALS, INC.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 Product Pipeline
12.10.6 SWOT Analysis
12.10.7 Key Developments
13. APPENDIX
13.1 ABOUT THE INSIGHT PARTNERS
13.2 GLOSSARY OF TERMS
LIST OF TABLES
TABLE 1. NORTH AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 2. NORTH AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 3. NORTH AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 4. US NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 5. US NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 6. US NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 7. CANADA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 8. CANADA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 9. CANADA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 10. MEXICO NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 11. MEXICO NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 12. MEXICO NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 13. EUROPE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 14. EUROPE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 15. EUROPE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 16. GERMANY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 17. GERMANY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 18. GERMANY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 19. UK NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 20. UK NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 21. UK NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 22. FRANCE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 23. FRANCE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 24. FRANCE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 25. ITALY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 26. ITALY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 27. ITALY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 28. SPAIN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 29. SPAIN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 30. SPAIN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 31. ASIA PACIFIC NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 32. ASIA PACIFIC NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 33. ASIA PACIFIC NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 34. CHINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 35. CHINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 36. CHINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 37. JAPAN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 38. JAPAN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 39. JAPAN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 40. INDIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 41. INDIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 42. INDIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 43. AUSTRALIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 44. AUSTRALIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 45. AUSTRALIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 46. SOUTH KOREA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 47. SOUTH KOREA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 48. SOUTH KOREA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 49. MIDDLE EAST & AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 50. MIDDLE EAST & AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 51. MIDDLE EAST & AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 52. UAE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 53. UAE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 54. UAE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 55. SAUDI ARABIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 56. SAUDI ARABIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 57. SAUDI ARABIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 58. SOUTH AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 59. SOUTH AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 60. SOUTH AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 61. SOUTH & CENTRAL AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 62. SOUTH & CENTRAL AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 63. SOUTH & CENTRAL AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 64. BRAZIL NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 65. BRAZIL NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 66. BRAZIL NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 67. ARGENTINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
TABLE 68. ARGENTINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)
TABLE 69. ARGENTINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY DISTRIBUTION CHANNEL (US$ MN)
TABLE 70. RECENT EXPANSIONS IN THE NARCOLEPSY MARKET
TABLE 71. RECENT PRODUCT LAUNCHES IN THE NARCOLEPSY MARKET
TABLE 72. OTHER ORGANIC GROWTH STRATEGIES IN THE NARCOLEPSY MARKET
TABLE 73. RECENT AGREEMENTS IN THE NARCOLEPSY MARKET
TABLE 74. RECENT ACQUISITIONS IN THE NARCOLEPSY MARKET
TABLE 75. RECENT OTHER INORGANIC GROWTH STRATEGIES IN THE NARCOLEPSY MARKET
TABLE 76. GLOSSARY OF TERMS, NARCOLEPSY MARKET
LIST OF FIGURES
FIGURE 1. NARCOLEPSY MARKET SEGMENTATION
FIGURE 2. BIOREACTORS SEGMENTATION, BY REGION
FIGURE 3. ASIA PACIFIC NARCOLEPSY MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
FIGURE 4. GLOBAL NARCOLEPSY MARKET BY TYPE, MARKET SHARE (%), 2018
FIGURE 5. GLOBAL NARCOLEPSY MARKET BY PRODUCT, MARKET SHARE (%), 2018
FIGURE 6. GLOBAL NARCOLEPSY MARKET BY DISTRIBUTION CHANNEL, MARKET SHARE (%), 2018
FIGURE 7. NORTH AMERICA PEST ANALYSIS
FIGURE 8. EUROPE PEST ANALYSIS
FIGURE 9. ASIA PACIFIC PEST ANALYSIS
FIGURE 10. MIDDLE EAST & AFRICA PEST ANALYSIS
FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 12. NARCOLEPSY MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS
FIGURE 13. GLOBAL NARCOLEPSY MARKET - REVENUE FORECASTS AND ANALYSIS -2018- 2027
FIGURE 14. GLOBAL NARCOLEPSY MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027
FIGURE 15. TYPE MARKET ANALYSIS AND FORECASTS 2018 AND 2027 (%)
FIGURE 16. NARCOLEPSY WITH CATAPLEXY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 17. NARCOLEPSY WITHOUT CATAPLEXY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 18. SECONDARY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 19. PRODUCT MARKET ANALYSIS AND FORECASTS 2018 AND 2027 (%)
FIGURE 20. CENTRAL NERVOUS SYSTEM STIMULANTS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 21. SODIUM OXYBATE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 22. ANTIDEPRESSANTS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 23. DISTRIBUTION CHANNEL MARKET ANALYSIS AND FORECASTS 2018 AND 2027 (%)
FIGURE 24. HOSPITAL PHARMACIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 25. RETAIL PHARMACIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 26. NORTH AMERICA NARCOLEPSY MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
FIGURE 27. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 28. NORTH AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 29. US NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 30. CANADA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 31. MEXICO NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 32. EUROPE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 33. EUROPE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 34. GERMANY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 35. UK NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 36. FRANCE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 37. ITALY NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 38. SPAIN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 39. ASIA PACIFIC NARCOLEPSY MARKET REVENUE OVERVIEW, BY COUNTRY (2018) (US $ MN)
FIGURE 40. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 41. ASIA PACIFIC NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 42. CHINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 43. JAPAN NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 44. INDIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 45. AUSTRALIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 46. SOUTH KOREA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 47. MIDDLE EAST & AFRICA NARCOLEPSY MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)
FIGURE 48. MIDDLE EAST & AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 49. MIDDLE EAST & AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
FIGURE 50. UAE NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 51. SAUDI ARABIA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 52. SOUTH AFRICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 53. SOUTH AND CENTRAL AMERICA NARCOLEPSY MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
FIGURE 54. SOUTH AND CENTRAL AMERICA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 55. SOUTH AND CENTRAL AMERICA NARCOLEPSY MARKET SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 56. BRAZIL NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 57. ARGENTINA NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
FIGURE 58. COMPARATIVE COMPANY ANALYSIS
FIGURE 59. GROWTH STRATEGIES IN THE NARCOLEPSY MARKET, 2015-2018
FIGURE 60. ORGANIC GROWTH STRATEGIES IN THE NARCOLEPSY MARKET, 2015-2018
FIGURE 61. INORGANIC GROWTH STRATEGIES IN THE BIOREACTOR MARKET, 2015-2018
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
